Organic compounds will continue to dominate molecular medicine as drug agents for the foreseeable future, and with few exceptions, these substances must be chemically synthesized. Synthesis enables the evaluation of bioactive organic molecules at all levels: cellular target identification, elucidation of biological mechanism, drug target validation, lead identification, and optimization and production of clinical candidates. The limitations of chemical synthesis often present a substantial obstacle to the study of bioactive molecules. Improved understanding of reactivity, development of effective and concise methods, and refinement of synthetic strategies are required to accelerate the process of understanding disease and advancing molecular medicine. This research will develop innovative methods to relieve these bottlenecks based on spirodiepoxides (SDEs), the double epoxidation products of allenes. Combined with flexible and convergent methods of allene synthesis, SDE-based transformations will enable direct entry into a wide range of molecular motifs that abound in natural products and complex pharmaceutical. The long-term goals of this research are to establish a in-depth understanding of SDE reactivity, to develop methods based on SDEs, and to refine synthetic strategies in the application of these methods to the synthesis of chemically and medicinally relevant targets.
The specific aims of this proposal are to develop methods for carbon nucleophile opening of SDEs and apply to the synthesis of 9-(S)-dihydroerythronolide A, a precursor to an important class of antibiotics. Second, to refine methods for stereoselective SDE formation and intramolecular heteroatom nucleophile SDE-openings focused on the synthesis of pyrans and furans and will be utilized in the synthesis of psymberin and pectenotoxin 4, which are antitumor agents. Lastly, we will develop methods for the synthesis of highly oxygenated motifs including vicinal polyols.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM078145-04
Application #
7782713
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Hagan, Ann A
Project Start
2007-03-01
Project End
2012-02-28
Budget Start
2010-03-01
Budget End
2011-02-28
Support Year
4
Fiscal Year
2010
Total Cost
$262,835
Indirect Cost
Name
Rutgers University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
001912864
City
New Brunswick
State
NJ
Country
United States
Zip Code
08901
Drahl, Michael A; Manpadi, Madhuri; Williams, Lawrence J (2013) C-C fragmentation: origins and recent applications. Angew Chem Int Ed Engl 52:11222-51
Sharma, Rojita; Williams, Lawrence J (2013) Oxetan-3-ones from allenes via spirodiepoxides. Org Lett 15:2202-5
Liu, Kai; Kim, Hiyun; Ghosh, Partha et al. (2011) Direct entry to erythronolides via a cyclic bis[allene]. J Am Chem Soc 133:14968-71
Sharma, Rojita; Manpadi, Madhuri; Zhang, Yue et al. (2011) Spirodiepoxide-based cascades: direct access to diverse motifs. Org Lett 13:3352-5
Joyasawal, Sipak; Lotesta, Stephen D; Akhmedov, N G et al. (2010) Spirodiepoxide strategy to the C ring of pectenotoxin 4: synthesis of the C1-C19 sector. Org Lett 12:988-91
Ghosh, Partha; Cusick, Joseph R; Inghrim, Jennifer et al. (2009) Silyl-substituted spirodiepoxides: stereoselective formation and regioselective opening. Org Lett 11:4672-5
Ghosh, Partha; Zhang, Yue; Emge, Thomas J et al. (2009) Modeling a macrocyclic bis[spirodiepoxide] strategy to erythronolide A. Org Lett 11:4402-5
Zhang, Yue; Cusick, Joseph R; Ghosh, Partha et al. (2009) Spirodiepoxides: synthesis of epoxomicinoids. J Org Chem 74:7707-14
Lotesta, Stephen D; Kiren, Sezgin; Sauers, Ronald R et al. (2007) Spirodiepoxides: heterocycle synthesis and mechanistic insight. Angew Chem Int Ed Engl 46:7108-11